Verdence Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.73M | Sell |
31,518
-7,396
| -19% | -$709K | 0.16% | 134 |
|
|
2025
Q4 | $3.74M | Sell |
38,914
-4,586
| -11% | -$445K | 0.22% | 105 |
|
|
2025
Q3 | $4.09M | Buy |
43,500
+14,104
| +48% | +$1.3M | 0.24% | 103 |
|
|
2025
Q2 | $2.56M | Buy |
29,396
+5,296
| +22% | +$449K | 0.18% | 125 |
|
|
2025
Q1 | $2.17M | Buy |
24,100
+12,877
| +115% | +$1.15M | 0.17% | 138 |
|
|
2024
Q4 | $897K | Buy |
11,223
+1,592
| +17% | +$138K | 0.07% | 262 |
|
|
2024
Q3 | $867K | Buy |
9,631
+885
| +10% | +$74.5K | 0.07% | 277 |
|
|
2024
Q2 | $688K | Sell |
8,746
-1,205
| -12% | -$98.8K | 0.06% | 301 |
|
|
2024
Q1 | $867K | Sell |
9,951
-7,438
| -43% | -$635K | 0.08% | 254 |
|
|
2023
Q4 | $1.43M | Sell |
17,389
-546
| -3% | -$41.6K | 0.14% | 170 |
|
|
2023
Q3 | $1.41M | Buy |
17,935
+2,480
| +16% | +$208K | 0.15% | 160 |
|
|
2023
Q2 | $1.36M | Buy |
15,455
+1,273
| +9% | +$110K | 0.16% | 157 |
|
|
2023
Q1 | $1.14M | Buy |
14,182
+2,109
| +17% | +$172K | 0.14% | 175 |
|
|
2022
Q4 | $938K | Buy |
12,073
+5,573
| +86% | +$452K | 0.12% | 182 |
|
|
2022
Q3 | $525K | Sell |
6,500
-94
| -1% | -$8.45K | 0.07% | 265 |
|
|
2022
Q2 | $592K | Sell |
6,594
-10,275
| -61% | -$1.04M | 0.08% | 261 |
|
|
2022
Q1 | $1.87M | Buy |
16,869
+3,932
| +30% | +$415K | 0.21% | 118 |
|
|
2021
Q4 | $1.34M | Sell |
12,937
-2,111
| -14% | -$244K | 0.16% | 140 |
|
|
2021
Q3 | $1.89M | Buy |
15,048
+621
| +4% | +$80.4K | 0.25% | 108 |
|
|
2021
Q2 | $1.79M | Buy |
14,427
+460
| +3% | +$57.8K | 0.25% | 107 |
|
|
2021
Q1 | $1.65M | Sell |
13,967
-776
| -5% | -$90.9K | 0.28% | 98 |
|
|
2020
Q4 | $1.73M | Buy |
14,743
+174
| +1% | +$19.2K | 0.33% | 86 |
|
|
2020
Q3 | $1.51M | Sell |
14,569
-15,789
| -52% | -$1.59M | 0.35% | 82 |
|
|
2020
Q2 | $2.78M | Sell |
30,358
-3,651
| -11% | -$350K | 0.69% | 34 |
|
|
2020
Q1 | $3.07M | Sell |
34,009
-1,704
| -5% | -$181K | 0.92% | 28 |
|
|
2019
Q4 | $4.05M | Buy |
35,713
+86
| +0.2% | +$9.44K | 0.99% | 25 |
|
|
2019
Q3 | $3.87M | Sell |
35,627
-9,097
| -20% | -$949K | 1.09% | 20 |
|
|
2019
Q2 | $4.36M | Sell |
44,724
-8,447
| -16% | -$771K | 1.25% | 13 |
|
|
2019
Q1 | $4.84M | Sell |
53,171
-4,440
| -8% | -$397K | 1.31% | 15 |
|
|
2018
Q4 | $5.24M | Sell |
57,611
-3,027
| -5% | -$283K | 1.47% | 19 |
|
|
2018
Q3 | $5.96M | Sell |
60,638
-4,868
| -7% | -$450K | 1.48% | 17 |
|
|
2018
Q2 | $5.61M | Sell |
65,506
-1,228
| -2% | -$103K | 1.36% | 19 |
|
|
2018
Q1 | $5.35M | Buy |
66,734
+1,819
| +3% | +$150K | 1.29% | 20 |
|
|
2017
Q4 | $5.24M | Buy |
+64,915
| New | +$5.2M | 1.25% | 24 |
|
Other funds holding MDT
VCM
VPM
Verdence Capital Advisors's MDT Position: Q1 2026 in Review
Verdence Capital Advisors reduced its Medtronic (MDT) stake by 19% in Q1 2026, selling an estimated $709K and leaving 31,518 shares worth $2.73M. The position accounts for 0.16% of the portfolio, ranked #134.
Verdence Capital Advisors first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.96M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Verdence Capital Advisors held 31,518 shares of Medtronic worth $2.73M as of Q1 2026.
- Verdence Capital Advisors sold 7,396 Medtronic shares in Q1 2026, an estimated $709K.
- Medtronic made up 0.16% of Verdence Capital Advisors's portfolio in Q1 2026, its #134 holding.
- Verdence Capital Advisors first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Verdence Capital Advisors's Medtronic position peaked at $5.96M in Q3 2018.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.